570 related articles for article (PubMed ID: 7828672)
1. Leukemic cells (HL-60) produce a novel extracellular matrix-degrading proteinase that is not inhibited by tissue inhibitors of matrix metalloproteinases (TIMPs).
Dittmann KH; Lottspeich F; Ries C; Petrides PE
Exp Hematol; 1995 Feb; 23(2):155-60. PubMed ID: 7828672
[TBL] [Abstract][Full Text] [Related]
2. Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro.
Schnaper HW; Grant DS; Stetler-Stevenson WG; Fridman R; D'Orazi G; Murphy AN; Bird RE; Hoythya M; Fuerst TR; French DL
J Cell Physiol; 1993 Aug; 156(2):235-46. PubMed ID: 8344982
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts.
Di Girolamo N; Lloyd A; McCluskey P; Filipic M; Wakefield D
Am J Pathol; 1997 Feb; 150(2):653-66. PubMed ID: 9033278
[TBL] [Abstract][Full Text] [Related]
4. Studies on the effects of laminin, E-8 fragment of laminin and synthetic laminin peptides PA22-2 and YIGSR on matrix metalloproteinases and tissue inhibitor of metalloproteinase expression.
Mackay AR; Gomez DE; Nason AM; Thorgeirsson UP
Lab Invest; 1994 Jun; 70(6):800-6. PubMed ID: 8015284
[TBL] [Abstract][Full Text] [Related]
5. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2).
Fridman R; Toth M; Peña D; Mobashery S
Cancer Res; 1995 Jun; 55(12):2548-55. PubMed ID: 7780967
[TBL] [Abstract][Full Text] [Related]
6. Characterization and novel activation of 72-kDa metalloproteinase in retinal interphotoreceptor matrix and Y-79 cell culture medium.
Jones BE; Moshyedi P; Gallo S; Tombran-Tink J; Arand G; Reid DA; Thompson EW; Chader GJ; Waldbillig RJ
Exp Eye Res; 1994 Sep; 59(3):257-69. PubMed ID: 7821370
[TBL] [Abstract][Full Text] [Related]
7. Quantitative reverse zymography: analysis of picogram amounts of metalloproteinase inhibitors using gelatinase A and B reverse zymograms.
Oliver GW; Leferson JD; Stetler-Stevenson WG; Kleiner DE
Anal Biochem; 1997 Jan; 244(1):161-6. PubMed ID: 9025922
[TBL] [Abstract][Full Text] [Related]
8. Processing of a precursor of 72-kilodalton type IV collagenase/gelatinase A by a recombinant membrane-type 1 matrix metalloproteinase.
Kinoshita T; Sato H; Takino T; Itoh M; Akizawa T; Seiki M
Cancer Res; 1996 Jun; 56(11):2535-8. PubMed ID: 8653693
[TBL] [Abstract][Full Text] [Related]
9. HL-60 leukemia cells produce an autocatalytically truncated form of matrix metalloproteinase-9 with impaired sensitivity to inhibition by tissue inhibitors of metalloproteinases.
Ries C; Lottspeich F; Dittmann KH; Petrides PE
Leukemia; 1996 Sep; 10(9):1520-6. PubMed ID: 8751473
[TBL] [Abstract][Full Text] [Related]
10. Production of matrix metalloproteinases at the bone-implant interface in loose total hip replacements.
Yokohama Y; Matsumoto T; Hirakawa M; Kuroki Y; Fujimoto N; Imai K; Okada Y
Lab Invest; 1995 Dec; 73(6):899-911. PubMed ID: 8558853
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
Ries C; Loher F; Zang C; Ismair MG; Petrides PE
Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
[TBL] [Abstract][Full Text] [Related]
12. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
[TBL] [Abstract][Full Text] [Related]
13. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells.
Lim YT; Sugiura Y; Laug WE; Sun B; Garcia A; DeClerck YA
J Cell Physiol; 1996 May; 167(2):333-40. PubMed ID: 8613475
[TBL] [Abstract][Full Text] [Related]
14. Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors.
Terada T; Okada Y; Nakanuma Y
Hepatology; 1996 Jun; 23(6):1341-4. PubMed ID: 8675149
[TBL] [Abstract][Full Text] [Related]
15. Secreted inhibitors of metalloproteinases (IMPs) that are distinct from TIMP.
Banda MJ; Howard EW; Herron GS; Apodaca G
Matrix Suppl; 1992; 1():294-8. PubMed ID: 1480040
[TBL] [Abstract][Full Text] [Related]
16. Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2.
Imai K; Ohuchi E; Aoki T; Nomura H; Fujii Y; Sato H; Seiki M; Okada Y
Cancer Res; 1996 Jun; 56(12):2707-10. PubMed ID: 8665498
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties.
Okada Y; Morodomi T; Enghild JJ; Suzuki K; Yasui A; Nakanishi I; Salvesen G; Nagase H
Eur J Biochem; 1990 Dec; 194(3):721-30. PubMed ID: 2269296
[TBL] [Abstract][Full Text] [Related]
18. Expression of matrix metalloproteinases and inhibitor by human retinal pigment epithelium.
Alexander JP; Bradley JM; Gabourel JD; Acott TS
Invest Ophthalmol Vis Sci; 1990 Dec; 31(12):2520-8. PubMed ID: 2176183
[TBL] [Abstract][Full Text] [Related]
19. Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases.
Fukuda Y; Ishizaki M; Kudoh S; Kitaichi M; Yamanaka N
Lab Invest; 1998 Jun; 78(6):687-98. PubMed ID: 9645759
[TBL] [Abstract][Full Text] [Related]
20. Expression of matrix metalloproteinases and their endogenous tissue inhibitors in skin lesions from patients with tuberous sclerosis.
Papakonstantinou E; Dionyssopoulos A; Aletras AJ; Pesintzaki C; Minas A; Karakiulakis G
J Am Acad Dermatol; 2004 Oct; 51(4):526-33. PubMed ID: 15389186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
